(Q57540681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

R H Herzig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M M Bortin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A J Barrett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

K G Blume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

E Gluckman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M M Horowitz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A Marmont

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

T Masaoka

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

H G Prentice

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

language of work or name

English

0 references

publication date

1 April 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

8536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

786-789

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

The ninth annual david karnofsky lecture.Treatment of acute lymphocytic leukemia

6 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Long-term survival in adult acute lymphoblastic leukemia: follow-up of a Southeastern Cancer Study Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

New directions in the treatment of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Initial features and prognosis in 363 children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Acute lymphoblastic leukaemia in children: Classification and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Differences in prognosis for boys and girls with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Combination chemotherapy for haematological relapse in adult acute lymphoblastic leukaemia (ALL)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Which treatment for childhood acute lymphoblastic leukaemia in second remission?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Relapse Following Marrow Transplantation for Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Bone marrow transplantation for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Maximum utilization of the life table method in analyzing survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

A computer program for comparing K samples with right-censored data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Late marrow recurrences in childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: a report from Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2992809-1

7 January 2021

10.1016/S0140-6736(87)92809-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2882192%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference